Simone A Huygens (Simone Huygens)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Polycyclic Aromatic Hydrocarbons

Metastatic Breast Cancer

Top Venues

Personalized medicine

PharmacoEconomics

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

This page only lists publications with an associated author ORCID identifier.

Publications

Maximiliaan L Notenboom, Reda Rhellab, Jonathan R G Etnel, Simone A Huygens, Jesper Hjortnaes, Jolanda Kluin, Johanna J M Takkenberg, Kevin M Veen
How microsimulation translates outcome estimates to patient lifetime event occurrence in the setting of heart valve disease. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 65 (3) (2024)
Rositsa Koleva-Kolarova, Heleen Vellekoop, Simone A Huygens, Matthijs M Versteegh, Maureen P M H Rutten-van Mölken, László Szilberhorn, Tamás Zelei, Balázs Nagy, Sarah Wordsworth, Apostolos Tsiachristas
Cost-effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK. Personalized medicine (2023)
László Szilberhorn, Tamás Zelei, Heleen Vellekoop, Simone A Huygens, Matthijs M Versteegh, Maureen P M H Rutten-van Mölken, Rositsa Koleva-Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, Balázs Nagy
Cost-effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries. Personalized medicine (2023)
Gábor Kovács, Dávid Nagy, László Szilberhorn, Tamás Zelei, Zsolt Gaál, Heleen Vellekoop, Simone A Huygens, Matthijs M Versteegh, Maureen P M H Rutten-van Mölken, Rositsa Koleva-Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, Balázs Nagy
Cost-effectiveness of genetic-based screening strategies for maturity-onset diabetes of the young. Personalized medicine (2023)
Balázs Nagy, Tamás Zelei, Heleen Vellekoop, Simone A Huygens, Matthijs M Versteegh, Maureen P M H Rutten-van Mölken, Rositsa Koleva-Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, László Szilberhorn
Lessons learned from the application of the HEcoPerMed guidance to three modeling case studies. Personalized medicine (2023)
Rositsa Koleva-Kolarova, László Szilberhorn, Tamás Zelei, Heleen Vellekoop, Balázs Nagy, Simone A Huygens, Matthijs M Versteegh, Maureen P M H Rutten-van Mölken, Sarah Wordsworth, Apostolos Tsiachristas
Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation. Personalized medicine (2023)
Heleen Vellekoop, Simone A Huygens, Matthijs M Versteegh, László Szilberhorn, Tamás Zelei, Balázs Nagy, Rositsa Koleva-Kolarova, Sarah Wordsworth, Maureen P M H Rutten-van Mölken, null null
Cost-effectiveness of alternative NTRK testing strategies in cancer patients followed by histology-independent therapy with entrectinib: an analysis of three European countries. Personalized medicine (2023)
Rositsa Koleva-Kolarova, Heleen Vellekoop, Simone A Huygens, Matthijs M Versteegh, Maureen P M H Rutten-van Mölken, László Szilberhorn, Tamás Zelei, Balázs Nagy, Sarah Wordsworth, Apostolos Tsiachristas
Budget impact and transferability of cost-effectiveness of DPYD testing in metastatic breast cancer in three health systems. Personalized medicine (2023)
Simone A Huygens, Matthijs M Versteegh, Stefan Vegter, L Jan Schouten, Tim A Kanters
Methodological Challenges in the Economic Evaluation of a Gene Therapy for RPE65-Mediated Inherited Retinal Disease: The Value of Vision. PharmacoEconomics 39 (4) (2021)
Heleen Vellekoop, Simone A Huygens, Matthijs M Versteegh, László Szilberhorn, Tamás Zelei, Balázs Nagy, Rositsa Koleva-Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, Maureen P M H Rutten-van Mölken, null null
Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine. PharmacoEconomics 39 (7) (2021)
Simone A Huygens, Lucas M A Goossens, Judith A van Erkelens, Johanna J M Takkenberg, Maureen P M H Rutten-van Mölken
How much does a heart valve implantation cost and what are the health care costs afterwards? Open heart 5 (1) (2018)